CoreTech Limited (MLCOT)
Market Closed
1 Jul, 15:30
XPAR XPAR Primary €
0. 09
+0.02
+20%
€
1.26M Market Cap
- P/E Ratio
- Div Yield
72,600 Volume
- Eps
€ 0.08
Previous Close Want to track MLCOT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
MLCOT closed Wednesday higher at €0.09, an increase of 20% from Tuesday's close, completing a monthly increase of 12.5% or €0.01. Over the past 12 months, MLCOT stock lost -28%.
MLCOT is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.
CoreTech Limited (MLCOT) FAQ
What is the stock price today?
The current price is €0.09.
On which exchange is it traded?
CoreTech Limited is listed on XPAR.
What is its stock symbol?
The ticker symbol is MLCOT.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 1.26M.
Has CoreTech Limited ever had a stock split?
No, there has never been a stock split.
CoreTech Limited Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Serge Goldner CEO | XPAR Exchange | - ISIN |
| FR Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Gour Medical SA is a notable pharmaceutical development company with a focus on veterinary solutions, particularly for pets. Founded in 2014, this innovative enterprise has established itself in the heart of Paris, France, dedicating its efforts to the advancement and distribution of novel veterinary products. With a strong inclination towards leveraging the therapeutic potentials of cannabidiol (CBD), Gour Medical SA has carved a niche for itself in the rapidly evolving pet healthcare market.
Products and Services
- Cannabidiol Solutions for Pets - Under the flagship brand WEEDLEY, Gour Medical SA offers a range of cannabidiol-based products specifically designed for pets. These solutions aim to address a multitude of health issues faced by pets today, leveraging the natural therapeutic properties of CBD. The product line encompasses a variety of formulations to suit the diverse needs and preferences of pets and their owners, ensuring accessibility to alternative veterinary care.
Contact Information
Address: 5, rue de Castiglione, Paris, France, 75001
Phone: 33 1 42 46 11 73
Website: https://reboostblockchaincorp.com
